These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3130575)

  • 1. Circulating interferon gamma in AIDS patients treated with interleukin-2.
    Murray HW; DePamphilis J; Schooley RT; Hirsch MS
    N Engl J Med; 1988 Jun; 318(23):1538-9. PubMed ID: 3130575
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma.
    Murphy PM; Lane HC; Gallin JI; Fauci AS
    Ann Intern Med; 1988 Jan; 108(1):36-41. PubMed ID: 3122616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation.
    Murray HW; Squires KE; Gassyuk-Botev E; DePamphilis JK
    Am J Med; 1992 Aug; 93(2):234. PubMed ID: 1497024
    [No Abstract]   [Full Text] [Related]  

  • 4. No new ways of treating AIDS.
    Maddox J
    Nature; 1984 Mar 8-14; 308(5955):107. PubMed ID: 6422309
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective combination therapy using interferon-gamma and interleukin-2 for disseminated Mycobacterium avium complex infection in a pediatric patient with AIDS.
    Sekiguchi Y; Yasui K; Yamazaki T; Agematsu K; Kobayashi N; Koike K
    Clin Infect Dis; 2005 Dec; 41(11):e104-6. PubMed ID: 16267723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.
    Khatri VP; Fehniger TA; Baiocchi RA; Yu F; Shah MH; Schiller DS; Gould M; Gazzinelli RT; Bernstein ZP; Caligiuri MA
    J Clin Invest; 1998 Mar; 101(6):1373-8. PubMed ID: 9502779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic developments in AIDS--1985.
    Jacobs JL; Murray HW
    Year Immunol; 1986; 2():323-8. PubMed ID: 3033948
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches to patients with AIDS.
    Lane HC; Masur H; Gelmann EP; Fauci AS
    Cancer Res; 1985 Sep; 45(9 Suppl):4674s-4676s. PubMed ID: 2990706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic reconstitution in the acquired immunodeficiency syndrome.
    Lane HC; Fauci AS
    Ann Intern Med; 1985 Nov; 103(5):714-8. PubMed ID: 2996405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.
    Murray HW; Welte K; Jacobs JL; Rubin BY; Mertelsmann R; Roberts RB
    J Clin Invest; 1985 Nov; 76(5):1959-64. PubMed ID: 2997299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma to treat patients with AIDS.
    Fuchs D; Reibnegger G; Werner-Felmayer G; Dierich MP; Wachter H
    J Acquir Immune Defic Syndr (1988); 1991; 4(3):297-300. PubMed ID: 1671412
    [No Abstract]   [Full Text] [Related]  

  • 12. Gamma interferon and AIDS.
    Moore JL; Poiesz BJ; Tomar RH; Merl SA; Ehrlich GD
    N Engl J Med; 1985 Feb; 312(7):442-3. PubMed ID: 3918265
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
    Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
    J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
    Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
    J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotech plays big role in efforts against AIDS.
    Fox JL
    Biotechnology (N Y); 1995 Mar; 13(3):206-7. PubMed ID: 9634762
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic developments in AIDS--1984.
    Jacobs JL; Murray HW
    Year Immunol; 1985; ():208-13. PubMed ID: 3939623
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of acquired immune deficiency syndrome with recombinant interleukin-2.
    Volberding P; Moody DJ; Beardslee D; Bradley EC; Wofsy CB
    AIDS Res Hum Retroviruses; 1987; 3(2):115-24. PubMed ID: 3113462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin 2. How to reconstruct the immune system].
    Agosto M
    Sidahora; 1995; ():24-5. PubMed ID: 11363212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.